Rock Springs Capital Management LP Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$2.5B
Holdings
138
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (138 positions)
| Stock | Value |
|---|---|
UNHUNITEDHEALTH GROUP INC | $128.4M |
NBIXNEUROCRINE BIOSCIENCES INC | $111.1M |
WCGEURWELLCARE HEALTH PLANS INC | $83.1M |
ISRGINTUITIVE SURGICAL INC | $82.3M |
AMRNAMARIN CORP PLC | $70.5M |
HCAHCA HEALTHCARE INC | $56.3M |
EHCENCOMPASS HEALTH CORP | $51.6M |
—SPARK THERAPEUTICS INC | $49.0M |
TFXTELEFLEX INC | $44.2M |
PCRXPACIRA BIOSCIENCES | $43.8M |
PODDINSULET CORP | $43.0M |
IRTCIRHYTHM TECHNOLOGIES INC | $41.1M |
EWEDWARDS LIFESCIENCES CORP | $40.4M |
ACHCACADIA HEALTHCARE COMPANY IN | $40.1M |
—MEDICINES CO | $40.0M |
ABBVABBVIE INC | $39.8M |
BSXBOSTON SCIENTIFIC CORP | $39.5M |
EXASEXACT SCIENCES CORP | $39.0M |
SYKSTRYKER CORP | $38.7M |
CHRSCOHERUS BIOSCIENCES INC | $38.1M |
VRTXVERTEX PHARMACEUTICALS INC | $34.4M |
BAXBAXTER INTL INC | $33.7M |
—RADIUS HEALTH INC | $33.5M |
CICIGNA CORP NEW | $32.9M |
IDXXIDEXX LABS INC | $32.7M |
PENPENUMBRA INC | $32.6M |
—PORTOLA PHARMACEUTICALS INC | $28.2M |
GLPGGALAPAGOS NV | $26.7M |
ALNYALNYLAM PHARMACEUTICALS INC | $26.6M |
ONCBEIGENE LTD | $26.3M |
RAREULTRAGENYX PHARMACEUTICAL IN | $26.0M |
SRPTSAREPTA THERAPEUTICS INC | $25.4M |
—ALDER BIOPHARMACEUTICALS INC | $24.5M |
2L9BLUEPRINT MEDICINES CORP | $24.5M |
AMGNAMGEN INC | $24.4M |
TMOTHERMO FISHER SCIENTIFIC INC | $23.6M |
MOHMOLINA HEALTHCARE INC | $23.5M |
MDGLMADRIGAL PHARMACEUTICALS INC | $23.5M |
INCYINCYTE CORP | $23.2M |
ALLKGUSDALLAKOS INC | $22.8M |
NVTA1EURINVITAE CORP | $21.7M |
WSTWEST PHARMACEUTICAL SVSC INC | $21.6M |
NVROEURNEVRO CORP | $20.8M |
ARGXARGENX SE | $20.7M |
SGENEURSEATTLE GENETICS INC | $20.7M |
ASNDASCENDIS PHARMA A S | $20.6M |
AFWALIGN TECHNOLOGY INC | $20.1M |
MRTXEURMIRATI THERAPEUTICS INC | $20.1M |
—RA PHARMACEUTICALS INC | $19.7M |
—EPIZYME INC | $19.1M |
ZLABZAI LAB LTD | $18.6M |
CELGCELGENE CORP | $18.4M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $18.1M |
FRPTFRESHPET INC | $17.7M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $16.8M |
IM8NINSMED INC | $15.7M |
—INTERSECT ENT INC | $14.8M |
ARDXARDELYX INC | $14.4M |
—BIOHAVEN PHARMACTL HLDG CO L | $14.3M |
—ACHILLION PHARMACEUTICALS IN | $13.8M |
SG7SAGE THERAPEUTICS INC | $13.0M |
NVCRNOVOCURE LTD | $12.9M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $12.9M |
ASMBASSEMBLY BIOSCIENCES INC | $12.8M |
GHGUARDANT HEALTH INC | $12.1M |
—IMMUNOMEDICS INC | $11.9M |
—AUDENTES THERAPEUTICS INC | $11.5M |
AGIOAGIOS PHARMACEUTICALS INC | $11.4M |
—OBSEVA SA | $11.3M |
FGENEURFIBROGEN INC | $11.3M |
—ODONATE THERAPEUTICS INC | $11.2M |
—RETROPHIN INC | $11.0M |
—GW PHARMACEUTICALS PLC | $10.9M |
TBPHTHERAVANCE BIOPHARMA INC | $10.7M |
ABTABBOTT LABS | $10.3M |
—TRANSLATE BIO INC | $10.2M |
—ZOGENIX INC | $10.0M |
CNCCENTENE CORP DEL | $9.9M |
BMRNBIOMARIN PHARMACEUTICAL INC | $9.6M |
PHRPHREESIA INC | $8.8M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $8.5M |
ANABANAPTYSBIO INC | $8.4M |
AM6AMICUS THERAPEUTICS INC | $8.0M |
MIRMMIRUM PHARMACEUTICALS INC | $7.9M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $7.9M |
FIXXEURHOMOLOGY MEDICINES INC | $7.7M |
QUREUNIQURE NV | $7.7M |
JNJJOHNSON & JOHNSON | $7.2M |
ACADACADIA PHARMACEUTICALS INC | $6.7M |
DVAXDYNAVAX TECHNOLOGIES CORP | $6.6M |
RYTMRHYTHM PHARMACEUTICALS INC | $6.6M |
ELVANTHEM INC | $6.5M |
PBYIPUMA BIOTECHNOLOGY INC | $6.3M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $6.2M |
—MEDICINES CO | $6.0M |
—PHASEBIO PHARMACEUTICALS INC | $5.9M |
KRTXKARUNA THERAPEUTICS INC | $5.9M |
SPROSPERO THERAPEUTICS INC | $5.6M |
—RTI SURGICAL HOLDINGS INC | $5.6M |
AXNX*AXONICS MODULATION TECH INC | $5.5M |
Page 1 of 2Next